Improving the adherence to antiretroviral therapy, a difficult but essential task for a successful HIV treatment—clinical points of view and practical considerations

SA Iacob, DG Iacob, G Jugulete - Frontiers in pharmacology, 2017 - frontiersin.org
HIV infection is responsible for one the most devastating human pandemics. The advent of
antiretroviral therapy has changed the course of the pandemic and saved millions of lives …

The association of HIV-related stigma to HIV medication adherence: a systematic review and synthesis of the literature

SM Sweeney, PA Vanable - AIDS and Behavior, 2016 - Springer
This paper provides a review of the quantitative literature on HIV-related stigma and
medication adherence, including:(1) synthesis of the empirical evidence linking stigma to …

Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression

S Swindells, JF Andrade-Villanueva… - … England Journal of …, 2020 - Mass Medical Soc
Background Simplified regimens for the treatment of human immunodeficiency virus type 1
(HIV-1) infection may increase patient satisfaction and facilitate adherence. Methods In this …

Long-acting cabotegravir and rilpivirine after oral induction for HIV-1 infection

C Orkin, K Arasteh… - … England Journal of …, 2020 - Mass Medical Soc
Background Long-acting injectable regimens may simplify therapy for patients with human
immunodeficiency virus type 1 (HIV-1) infection. Methods We conducted a phase 3 …

[HTML][HTML] Phase 3 study of ibalizumab for multidrug-resistant HIV-1

B Emu, J Fessel, S Schrader, P Kumar… - … England Journal of …, 2018 - Mass Medical Soc
Abstract Background Ibalizumab, a humanized IgG4 monoclonal antibody, blocks the entry
of human immunodeficiency virus type 1 (HIV-1) by noncompetitive binding to CD4. Methods …

Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis

N Langebeek, EH Gisolf, P Reiss, SC Vervoort… - BMC medicine, 2014 - Springer
Background Adherence to combination antiretroviral therapy (ART) is a key predictor of the
success of human immunodeficiency virus (HIV) treatment, and is potentially amenable to …

Adherence to antiretroviral therapy and virologic failure: a meta-analysis

WM Bezabhe, L Chalmers, LR Bereznicki… - Medicine, 2016 - journals.lww.com
Adherence to Antiretroviral Therapy and Virologic Failure: A... : Medicine Adherence to
Antiretroviral Therapy and Virologic Failure: A Meta-Analysis : Medicine Log in or Register …

Long-acting antiretrovirals: a new era for the management and prevention of HIV infection

P Thoueille, E Choong, M Cavassini… - Journal of …, 2022 - academic.oup.com
The long-acting antiretroviral cabotegravir and rilpivirine combination has just received FDA,
EMA and Health Canada approval. This novel drug delivery approach is about to …

Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis

JB Nachega, OA Uthman, J Anderson, K Peltzer… - Aids, 2012 - journals.lww.com
Objective: To estimate antiretroviral therapy (ART) adherence rates during pregnancy and
postpartum in high-income, middle-income, and low-income countries. Design: Systematic …

Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International …

MA Thompson, MJ Mugavero, KR Amico… - Annals of internal …, 2012 - acpjournals.org
Description: After HIV diagnosis, timely entry into HIV medical care and retention in that care
are essential to the provision of effective antiretroviral therapy (ART). Adherence to ART is …